Reaction
Chronic Allograft Nephropathy reporting signals
As of the last recalculation, Chronic Allograft Nephropathy appears in 778 FAERS reports alongside 29 co-occurring drug terms. The strongest observed disproportionality signal is TACROLIMUS (PRR 299.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tacrolimus | 540 | 299.2 | 300.3 |
| Basiliximab | 108 | 285.1 | 287.8 |
| Tacrolimus Ointment 0.1% | 462 | 242.9 | 243.8 |
| Tacrolimus Extended-Release Capsules | 462 | 242.2 | 243.1 |
| Anti-Thymocyte Globulin (Rabbit) | 64 | 231.2 | 233.0 |
| Mycophenolate Mofetil Hydrochloride | 435 | 192.7 | 193.4 |
| Mycophenolate Mofetil | 434 | 192.1 | 192.7 |
| Sirolimus | 73 | 159.9 | 160.7 |
| Mycophenolic Acid | 120 | 118.4 | 118.9 |
| Mycophenilic Acid | 72 | 102.3 | 102.7 |
| Cyclosporine | 167 | 50.9 | 50.9 |
| Everolimus Tablets | 30 | 49.7 | 49.8 |
| Valganciclovir Hydrochloride Powder, | 17 | 38.1 | 38.2 |
| Ganciclovir | 14 | 37.2 | 37.3 |
| Ganciclovir Sodium | 14 | 36.0 | 36.1 |
| Valganciclovir | 24 | 35.1 | 35.2 |
| Valganciclovir Hydrochloride | 24 | 35.1 | 35.2 |
| Pyrazinamide | 10 | 28.8 | 28.9 |
| Abacavir Sulfate | 10 | 27.8 | 27.8 |
| Azathioprine | 79 | 26.6 | 26.6 |
| Prednisolone | 133 | 23.6 | 23.6 |
| Prednisolone Oral | 133 | 23.6 | 23.6 |
| Prednisolone Oral Solution | 133 | 23.6 | 23.6 |
| Rifampin | 10 | 18.6 | 18.6 |
| Isoniazid | 11 | 18.4 | 18.4 |
| Ritonavir 100 Mg | 10 | 18.1 | 18.1 |
| Efavirenz | 7 | 16.9 | 17.0 |
| Everolimus | 30 | 16.4 | 16.4 |
| Paricalcitol | 4 | 7.6 | 7.6 |